ProPhase Labs, Inc. financials

PRPH CIK 0000868278

Source: EDGAR filings · Built 2026-06-19T01:27:08Z

Key metrics by reporting period

Up to six most-recent periods side-by-side. Rows are the curated key lines — revenue, margins, cash, debt, equity, cash-flow totals, plus the derived and valuation metrics we compute on top. For every tag a filer reported in one period, use the single-filing drilldown below.

Derived Metrics

Concept FY 2025FY 2024FY 2023FY 2022FY 2021FY 2021
Free Cash Flow -8.34M -18.44M -13.97M 24.63M -17.85M
EBITDA -13.21M -32.44M -15.17M 28.31M 13.04M
Working Capital -49.93M -1.50M 26.73M 44.76M 45.79M
Net Debt 3.62M 12.23M 16.82M -2.11M 6.45M
Gross Margin 31.85% -2.22% 44.47% 57.61% 53.12%
Operating Margin -415.35% -570.59% -60.66% 19.24% 12.40%
Net Margin -339.31% -788.24% -47.97% 15.05% 7.94%
Return on Equity (ROE) -420.27% -725.74% -33.98% 29.02% 10.70%
Return on Assets (ROA) -24.62% -84.44% -18.26% 21.06% 7.03%
Current Ratio 0.06× 0.95× 2.28× 3.78× 3.95×
Debt-to-Equity 1.06× 1.76× 0.37× 0.11× 0.25×
Effective Tax Rate 0.00% -17.00% 26.87% 19.40% -18.25%
Cash Conversion Ratio 0.57× 0.33× 0.71× 1.55× -2.17×
Accruals Ratio -0.11× -0.57× -0.05× -0.12× 0.22×
SBC % of Revenue 43.57% 53.74% 10.11% 3.25% 4.03%
CapEx Coverage -19.36× -5.70× 7.29× -3.22×
Free Cash Flow Per Share $-0.98 $-9.22 $-0.81 $1.32 $-0.97

Income Statement

Concept FY 2025FY 2024FY 2023FY 2022FY 2021FY 2021
Revenue from Contract with Customer, Excluding Assessed Tax 4.34M 6.77M 34.98M 122.65M 79.04M
Cost of Goods and Services Sold 2.96M 6.92M 19.43M 51.99M 37.05M
Gross Profit 1.38M -150.00K 15.56M 70.65M 41.99M
Research and Development Expense 107.00K 594.00K 1.40M 652.00K 520.00K
Operating Expenses 19.43M 38.48M 36.78M 47.06M 32.19M
Operating Income (Loss) -18.05M -38.63M -21.22M 23.59M 9.80M
Income Tax Expense (Benefit) 0 7.20M -6.02M 4.45M -968.00K
Net Income (Loss) Attributable to Parent -14.74M -53.36M -16.78M 18.46M 6.27M
Earnings Per Share, Basic $-1.74 $-26.68 $-0.98 $1.17 $0.41
Weighted Average Number of Shares Outstanding, Basic 8.49M 2.00M 17.21M 15.85M 15.17M
Earnings Per Share, Diluted $-1.74 $-26.68 $-0.98 $1.02 $0.40
Weighted Average Number of Shares Outstanding, Diluted 8.49M 2.00M 17.21M 18.65M 18.39M

Balance Sheet

Concept FY 2025FY 2024FY 2023FY 2022FY 2021FY 2021
Cash and Cash Equivalents, at Carrying Value 90.00K 678.00K 1.61M 9.11M 8.41M
Assets, Current 3.15M 30.64M 47.59M 60.83M 61.32M
Assets 59.87M 63.20M 91.93M 87.65M 89.30M
Liabilities, Current 53.08M 32.13M 20.86M 16.07M 15.52M
Long-term Debt, Excluding Current Maturities 2.92M 0
Liabilities 56.36M 55.85M 42.54M 24.02M 30.67M
Stockholders' Equity Attributable to Parent 3.51M 7.35M 49.38M 63.63M 58.63M
Common Stock, Shares, Outstanding 8.97M 2.99M 18.05M 16.21M 15.49M

Cash Flow Statement

Concept FY 2025FY 2024FY 2023FY 2022FY 2021FY 2021
Net Cash Provided by (Used in) Operating Activities -8.34M -17.54M -11.89M 28.55M -13.62M
Net Cash Provided by (Used in) Investing Activities 920.00K 2.42M -1.37M -2.08M -19.67M
Payments for Repurchase of Common Stock 0 588.00K 2.15M 917.00K
Payments of Dividends 0 9.35M 4.55M
Net Cash Provided by (Used in) Financing Activities 6.84M 14.19M 5.76M -26.02M 35.13M

Raw XBRL tagging for a single filing

Every us-gaap and custom concept the filer tagged for one fiscal period, grouped by statement. Start here when a number in the trend table above surprises you and you want to see the exact tag behind it. Derived and valuation rows are omitted here because they already appear in the trend table.

Most recent filing shown by default.

Compare filings side-by-side

Diff any two filings with deltas and added / removed tags.

Immaterial rows are USD line items under 1% of the period's revenue — the noise floor below which a single tag rarely moves the investment thesis. Revenue is read from the filer's top-line concept (Revenues / RevenueFromContractWithCustomerExcludingAssessedTax, with a fallback chain). Non-USD rows, rows without a numeric value, and every row on a filing with no identifiable revenue anchor stay visible. Flip the switch off to see every tag the filer reported for the period.

Loading filing details…

Methodology

All facts on this page come straight from SEC EDGAR XBRL company-facts filings (PRPH CIK 0000868278), grouped by financial statement using FASB's base us-gaap presentation taxonomy. Filers may re-parent concepts onto different statements in their own extension taxonomy, so a handful of rows can show up under a different statement than on the actual 10-K / 10-Q; custom concepts and any we couldn't map fall into Other. Hover a cell to see the fully-qualified concept name and the filer's description.

For the full methodology — statement grouping, the Other bucket, derived metrics, and fact tooltips — see the methodology reference for the statement grouping, the "Other" bucket, derived metrics, and fact tooltips.

Related tickers

AMXOF

AMERICA MOVIL SAB DE CV/

GOOD

GLADSTONE COMMERCIAL CORP

PSTV

PLUS THERAPEUTICS, INC.